<DOC>
	<DOC>NCT01052155</DOC>
	<brief_summary>Accuracy of Point of Care (POC) or In-office Urine Drug Testing (Immunoassay) in Chronic Pain Patients: A Prospective Analysis of Immunoassay and Liquid Chromatography Tandem Mass Spectometry (LC/MS/MS)</brief_summary>
	<brief_title>Accuracy of Point of Care (POC) or In-office Urine Drug Testing (Immunoassay) in Chronic Pain Patients</brief_title>
	<detailed_description>Recruitment is indicated in patients with chronic pain management with or without controlled substance therapy. This is a diagnostic accuracy study performed in an interventional pain management referral center in the United States.</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<criteria>Inclusion criteria: â€¢ Chronic pain management with or without controlled substance therapy. Exclusion criteria:</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Controlled substances</keyword>
	<keyword>Opioids</keyword>
	<keyword>Benzodiazepines</keyword>
	<keyword>Illicit drugs</keyword>
	<keyword>Immunoassay drug testing</keyword>
	<keyword>Point of care (POC) testing</keyword>
	<keyword>Liquid Chromatography Tandem Mass Spectometry</keyword>
</DOC>